VIM and breast carcinoma: However, many other proteins – including glutathione-S-transferase [5], β2-microglobulin [6], heat shock protein (HSP)27 [7,8], 14-3-3σ [9,10], and vimentin [11] – have also been implicated in breast cancer drug resistance.